TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

Anhang
Lfd.
Vorstellung
Leukozyten CSF CSF CSF Protein
Leukozyten CCL19 CCL19
Nr. Diagnose
Therapie CSF Neutrophile Lymphozyten Monozyten CSF IgA CSF IgA serum Blut CSF Serum
/3µl % % % mg/dl µg/ml µg/ml 10³/µl pg/ml pg/ml
26 SRMA T Therapie 0 14 23 159 10 135.5 112
27 SRMA T Therapie 2 12 0.35 67.8 12 131.1 116.6
28 SRMA T Therapie 1 16 3.9 308 12 187 0
29 SRMA T Therapie 2 14 2.6 85 7 0 115.6
30 SRMA T Therapie 1 10 0.42 175 14 74.6 537.7
31 SRMA T Therapie 2 11 0.32 306 10 55 35
32 SRMA T Therapie 1 12 0.09 56.8 16 289.8 137
33 SRMA T Therapie 1 15.8 0.122 45 10 99.7 182.1
34 SRMA T Therapie 1 12 0.26 37 10 79.6 54.9
35 SRMA T Therapie 0 11 0.2 29 11 66.3 90.1
36 SRMA T Therapie 2 12 0.1 130 11 40.1 19.4
37 SRMA T Therapie 4 14 0.57 87 10 75 145.6
38 SRMA T Therapie 0 12 0.2 70 10 49.4 13.8
39 SRMA T Therapie 2 17 0.97 67 12 121.7 97
40 SRMA T Therapie 16 16 0.46 75 17 137.5 78.8
41 SRMA T Therapie 2 15.5 0.09 170 16 81.6 32.5
42 SRMA T Therapie 2 13 0.056 62 19 115.4 55.3
43 SRMA T Therapie 2 7 0.033 31 8 97.6 41.2
44 SRMA T Therapie 0 9.95 0.4 102 14 73.9 33.4
45 SRMA T Therapie 1 11 0.48 43.4 10 67.2 37
46 SRMA T Therapie 0 11 0.2 82.6 8 70.4 58
47 SRMA T Therapie 2 9 0.06 88.9 12 81.4 177
48 SRMA T Therapie 1 10 0.09 75.7 17 88.1 111.4
49 SRMA T Therapie 3 13 0.05 45.05 11 84.5 251
50 SRMA T Therapie 0 13 0.05 81 10 28.7 16.8
51 SRMA T Therapie 0 10 0.06 30 19 72.6 379.8
SRMA: Steroid-responsive meningitis-arteritis, CSF: Liquor cerebrospinalis, C:
Erstvorstellung, R: rezidiv, T: Therapie mit Glukokortikosteroiden, Lfd. Nr.: laufende
Nummer; CCL19: Marophagen inflammatorisches Protein-3β
136